Thrivent Financial for Lutherans Purchases 58,499 Shares of SPDR S&P Biotech ETF $XBI

by · The Markets Daily

Thrivent Financial for Lutherans lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 75.5% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 135,944 shares of the exchange traded fund’s stock after buying an additional 58,499 shares during the period. Thrivent Financial for Lutherans owned about 0.25% of SPDR S&P Biotech ETF worth $11,274,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Continental Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 40.1% in the second quarter. Continental Advisors LLC now owns 36,700 shares of the exchange traded fund’s stock worth $3,044,000 after acquiring an additional 10,500 shares in the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 99.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,380 shares of the exchange traded fund’s stock valued at $197,000 after purchasing an additional 1,189 shares in the last quarter. Evergreen Capital Management LLC grew its position in shares of SPDR S&P Biotech ETF by 32.1% in the 2nd quarter. Evergreen Capital Management LLC now owns 6,686 shares of the exchange traded fund’s stock valued at $554,000 after purchasing an additional 1,625 shares during the period. Headlands Technologies LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $445,000. Finally, Corient Private Wealth LLC increased its stake in SPDR S&P Biotech ETF by 55.3% during the 2nd quarter. Corient Private Wealth LLC now owns 89,396 shares of the exchange traded fund’s stock worth $7,414,000 after purchasing an additional 31,817 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $120.94 on Thursday. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $125.87. The firm’s 50 day moving average price is $114.56 and its two-hundred day moving average price is $98.15. The firm has a market cap of $7.34 billion, a P/E ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also